We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.81B
AUM Growth
-$531M
Cap. Flow
-$1.18B
Cap. Flow %
-24.44%
Top 10 Hldgs %
18.16%
Holding
673
New
167
Increased
91
Reduced
97
Closed
256

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$59.4M
2
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$56.3M
3
SPG icon
Simon Property Group
SPG
+$52M
4
TSM icon
TSMC
TSM
+$45.4M
5
M icon
Macy's
M
+$44.3M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$167M
2
GDI
GARDNER DENVER,INC
GDI
+$60.4M
3
BMC
BMC SOFTWARE, INC
BMC
+$58.7M
4
SFD
SMITHFIELD FOODS,INC
SFD
+$55.2M
5
AAP icon
Advance Auto Parts
AAP
+$48.2M

Sector Composition

Rank Sector Weight
1 Real Estate 14.75%
2 Consumer Staples 11.78%
3 Consumer Discretionary 6.16%
4 Financials 6.01%
5 Industrials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACHN
551
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-51,000
Closed -$417K
WCG
552
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-18,000
Closed -$1M
SRCI
553
DELISTED
SRC Energy Inc
SRCI
– –
-50,000
Closed -$366K
HOS
554
DELISTED
Hornbeck Offshore Services, Inc.
HOS
– –
-188,600
Closed -$10.1M
APC
555
DELISTED
Anadarko Petroleum
APC
– –
-33,042
Closed -$2.84M
ARRY
556
DELISTED
Array Biopharma Inc
ARRY
– –
-200,000
Closed -$908K
WFT
557
DELISTED
Weatherford International plc
WFT
– –
-500,000
Closed -$6.85M
HZNP
558
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-120,000
Closed -$295K
RDC
559
DELISTED
Rowan Companies Plc
RDC
– –
-333,802
Closed -$11.4M
ECYT
560
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
-38,000
Closed -$499K
ESRX
561
DELISTED
Express Scripts Holding Company
ESRX
– –
-67,000
Closed -$4.13M
AET
562
DELISTED
Aetna Inc
AET
– –
-34,000
Closed -$2.16M
GXP
563
DELISTED
Great Plains Energy Incorporated
GXP
– –
-269,155
Closed -$6.07M
IPXL
564
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-137,000
Closed -$2.73M
CAA
565
DELISTED
CalAtlantic Group, Inc.
CAA
– –
-155,152
Closed -$6.46M
CBF
566
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
– –
-470,428
Closed -$8.93M
CEMP
567
DELISTED
Cempra, Inc.
CEMP
– –
-100,000
Closed -$783K
BHI
568
CALL
DELISTED
Baker Hughes
BHI
– –
-35,200
Closed -$12K
BHI
569
DELISTED
Baker Hughes
BHI
– –
-410,397
Closed -$19.8M
YHOO
570
DELISTED
Yahoo Inc
YHOO
– –
-786,805
Closed -$19.8M
FNBC
571
DELISTED
First NBC Bank Holding Company
FNBC
– –
-229,129
Closed -$5.59M
ARIA
572
DELISTED
Ariad Pharmaceuticals Inc
ARIA
– –
-50,000
Closed -$874K
GGP
573
DELISTED
GGP Inc.
GGP
– –
-1,897,428
Closed -$37.7M
RAX
574
CALL
DELISTED
Rackspace Hosting Inc
RAX
– –
-25,000
Closed -$91K
ITC
575
DELISTED
ITC HOLDINGS CORP
ITC
– –
-104,997
Closed -$3.19M
21 22
23
24 25

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return

UBS O'Connor's Q3 2013 Portfolio in Review

As of Q3 2013, UBS O'Connor held 673 positions worth $4.81B, down 9.9% from $5.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS O'Connor withdrew a net $1.18B in Q3 2013, closing 256 positions and reducing 97 holdings. Its most notable exit was Pfizer, an estimated $167M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 15% of assets, up from 13% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, UBS O'Connor opened a new position in Colgate-Palmolive worth $59.4M.

  • UBS O'Connor's largest Q3 2013 buy was Colgate-Palmolive: 1,002,498 shares worth $59.4M.
  • UBS O'Connor added most to ONYX PHARMACEUTICALS INC in Q3 2013, an estimated $56.3M increase.
  • UBS O'Connor's biggest Q3 2013 reduction was Advance Auto Parts, cutting an estimated $48.2M.
  • UBS O'Connor fully exited Pfizer in Q3 2013, selling an estimated $167M.
  • UBS O'Connor's ten largest holdings make up 18% of its $4.81B portfolio in Q3 2013.
  • UBS O'Connor opened 167 new positions and closed 256 in Q3 2013.
  • UBS O'Connor's portfolio value fell 9.9% quarter-over-quarter to $4.81B.

Based on UBS O'Connor's 13F filing for Q3 2013, filed 14 Nov 2013.